JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB257224

Human HNRNPA2B1 knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

HNRNPA2B1 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 2 bp deletion in exon 3.

View Alternative Names

HNRPA2, HNRPA2B1, HNRPB1, Heterogeneous nuclear ribonucleoprotein A2, Heterogeneous nuclear ribonucleoprotein A2/B1, Heterogeneous nuclear ribonucleoprotein B1, Heterogeneous nuclear ribonucleoproteins A2/B1, Hnrnpa2b1, Nuclear ribonucleoprotein particle A2 protein, RNP-A2, RNP-B1, ROA2_HUMAN, SNRPB1, hnRNP A2 / hnRNP B1, hnRNP A2/B1, hnRNP-A2, hnRNP-B1

3 Images
Western blot - Human HNRNPA2B1 knockout HEK-293T cell lysate (AB257224)
  • WB

Lab

Western blot - Human HNRNPA2B1 knockout HEK-293T cell lysate (AB257224)

Lane 1 : Wild-type HEK-293T (human embryonic kidney epithelial cell), whole cell lysate 20 μg

Lane 2 : hnRNP A2B1 knockout HEK-293T (human embryonic kidney epithelial cell), whole cell lysate ​20 μg

Lane 3 : HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate 20 μg

Lane 4 : A431 (human epidermoid carcinoma epithelial cell), whole cell lysate 20 μg

Lane 5 : K562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate 20 μg

Blocking and diluting buffer and concentration : Intercept® (TBS) Blocking Buffer diluted with an equal volume of 0.1% TBS

Lanes 1- 4 : Merged signal (red and green). Green - ab259894 observed at 36/38kDa. Red - loading control ab7291 (Mouse monoclonal [DM1A] to alpha Tubulin) observed at 50 kDa.

Lanes 1-2 : ab259894 Anti-hnRNP A2B1 antibody was shown to react with hnRNP A2B1 in HEK-293T cells in Western blot. Loss of signal was observed when hnRNP A2B1 knockout cell line ab266404 (knockout cell lysate ab257224) was used. Wild-type and hnRNP A2B1 knockout samples were subjected to SDS-PAGE.

ab259894 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated at 4°C overnight at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat Anti-Rabbit IgG H&L (IRDye® 800CW) (ab216773) and Goat Anti-Mouse IgG H&L (IRDye® 680RD) (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-hnRNP A2B1 antibody [EPR24002-81] (<a href='/en-us/products/primary-antibodies/hnrnp-a2b1-antibody-epr24002-81-ab259894'>ab259894</a>) at 1/1000 dilution

Lane 1:

Wild-type HEK-293T (human embryonic kidney epithelial cell), whole cell lysate at 20 µg

Lane 2:

hnRNP A2B1 knockout HEK-293T (human embryonic kidney epithelial cell), whole cell lysate at 20 µg

Lane 2:

Western blot - Human HNRNPA2B1 knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-hnrnpa2b1-knockout-hek-293t-cell-line-ab266404'>ab266404</a>)

Lane 3:

HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 20 µg

Lane 4:

A431 (human epidermoid carcinoma epithelial cell), whole cell lysate at 20 µg

Lane 5:

K562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG H&L (IRDye® 800CW) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) and Goat Anti-Mouse IgG H&L (IRDye® 680RD) (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/10000 dilution

Predicted band size: 37 kDa

Observed band size: 36 kDa,38 kDa

false

Western blot - Human HNRNPA2B1 knockout HEK-293T cell lysate (AB257224)
  • WB

Lab

Western blot - Human HNRNPA2B1 knockout HEK-293T cell lysate (AB257224)

Lane 1 : Wild-type HEK293T cell lysate (20 μg)

Lane 2 : HNRNPA2B1 knockout HEK293T cell lysate (20 μg)

Lane 3 : A549 cell lysate (20 μg)

Lanes 1-3 : Merged signal (red and green). Green - ab31645 observed at 37 kDa. Red - loading control, ab7291 observed at 50 kDa.

ab31645 Anti-hnRNP A2B1 antibody was shown to specifically react with hnRNP A2B1 in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266404 (knockout cell lysate ab257224) was used. Wild-type and hnRNP A2B1 knockout samples were subjected to SDS-PAGE. ab31645 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti- Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti- Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-hnRNP A2B1 antibody (<a href='/en-us/products/primary-antibodies/hnrnp-a2b1-antibody-ab31645'>ab31645</a>) at 1/500 dilution

Lane 1:

Wild-type HEK293T cell lysate at 20 µg

Lane 2:

HNRNPA2B1 knockout HEK293T cell lysate at 20 µg

Lane 3:

A549 cell lysate at 20 µg

Predicted band size: 37 kDa

Observed band size: 37 kDa

false

Sanger Sequencing - Human HNRNPA2B1 knockout HEK-293T cell lysate (AB257224)
  • Sanger seq

Unknown

Sanger Sequencing - Human HNRNPA2B1 knockout HEK-293T cell lysate (AB257224)

Homozygous : 2 bp deletion in exon 3

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 2 bp deletion in exon 3.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab257224-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human HNRNPA2B1 knockout HEK293T cell lysate", "number":"AB257224-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB257224-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
HNRNPA2B1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

HnRNP A2B1 sometimes referred to as heterogeneous nuclear ribonucleoprotein A2/B1 is a multifunctional protein involved in RNA binding and processing. It has a molecular mass of about 38-43 kDa. The protein is expressed in various tissues with high expression levels observed in the brain and liver. hnRNP A2B1 participates in a range of RNA-related processes playing a significant role in mRNA metabolism and transport.
Biological function summary

HnRNP A2B1 contributes to alternative splicing RNA stability and translational regulation. This protein typically associates with complex assemblies that manage RNA processing and transport mechanisms. It interacts with other proteins within the heterogeneous nuclear ribonucleoprotein family collaborating in the regulation of mRNA cycling between the nucleus and cytoplasm affecting gene expression patterns.

Pathways

HnRNP A2B1 exhibits critical involvement in the mRNA splicing pathway and RNA transport pathways. It frequently interacts with proteins such as hnRNP A1 and hnRNP C where they collectively influence pre-mRNA processing and splicing dictating proper RNA maturation and cell function. These pathways are important for maintaining cellular homeostasis and responding to cellular signals.

HnRNP A2B1 is linked to neurodegenerative diseases and certain cancers. Abnormal expression or mutations of hnRNP A2B1 are associated with Alzheimer's disease implicating the protein in amyloid precursor protein processing. Additionally dysregulation of this protein shows correlation with breast cancer progression. Proteins like tau and other hnRNPs connect with hnRNP A2B1 in these conditions suggesting a significant role in pathological states.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com